Gf Fund Management Co. Ltd. Arbutus Biopharma Corp Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,778 shares of ABUS stock, worth $17,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,778
Previous 4,124
8.39%
Holding current value
$17,076
Previous $18.7 Million
2.94%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABUS
# of Institutions
193Shares Held
116MCall Options Held
2.67MPut Options Held
693K-
Morgan Stanley New York, NY24.5MShares$111 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$60.3 Million22.38% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$52.2 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY11MShares$49.7 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$41.8 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $678M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...